Nanobiotix S.A. (NBTX) Financials

NBTX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2025 53.2 million 134.5 million
March 31, 2025 72.9 million 144.0 million
Dec. 31, 2024 70.2 million 138.6 million
June 30, 2024 93.1 million 116.4 million

NBTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2025 -20.7 million 2.5 million
March 31, 2025 -15.2 million 2.6 million
Dec. 31, 2024 -14.7 million 2.5 million
June 30, 2024 -6.8 million 2.1 million

NBTX Net Income

No data available :(

NBTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2025 34.0 million 52.0 million 4.3 million
March 31, 2025 53.8 million - -
Dec. 31, 2024 51.8 million 44.8 million 4.4 million
June 30, 2024 71.2 million 43.7 million 5.0 million

NBTX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2025 55.9 million
March 31, 2025 51.1 million
Dec. 31, 2024 49.4 million
June 30, 2024 50.6 million

NBTX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2025 176799 17.1 million 13.3 million -
March 31, 2025 388370 20.1 million 21.7 million -
Dec. 31, 2024 373839 19.3 million 10.1 million -
June 30, 2024 524942 23.6 million 11.6 million -

NBTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2025 31.4 million -
March 31, 2025 -22.6 million -
Dec. 31, 2024 -21.8 million -
June 30, 2024 10.0 million -

NBTX

Price: $35.20

52 week price:
3.26
55.07

Payout Ratio Range:
-354.45%
-16.62%

Earnings Per Share: -0.58 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: France

Volume: 700

Market Capitalization: 1.5 billion

Links: